For the third quarter of fiscal year 2023 ending June 30 2023, HOLOGIC ($NASDAQ:HOLX) reported total revenue of USD 984.4 million and a net loss of USD 40.5 million, compared to total revenue of USD 228.4 million for the same period in the preceding year, representing a decrease of 1.8%.
GoodWhale is a great tool to analyze HOLOGIC‘s financials. The Star Chart shows that HOLOGIC is strong in assets and profitability, but medium in growth and weak in dividend. Since HOLOGIC is classified as a ‘rhino’, a company that has achieved moderate revenue or earnings growth, it is likely to be interesting to value-oriented investors who are looking for stable returns. Additionally, HOLOGIC has a high health score of 8/10, which means it is capable to safely ride out any crisis without the risk of bankruptcy. This makes it an attractive option for investors who are looking for lower volatility investments. More…
Risk Rating Analysis
Star Chart Analysis
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for Hologic. HOLOGIC_Reports_Q3_FY2023_Revenue_of_984.4_Million_Net_Income_of_-40.5_Million_Down_1.8_from_Last_Year”>More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Hologic. HOLOGIC_Reports_Q3_FY2023_Revenue_of_984.4_Million_Net_Income_of_-40.5_Million_Down_1.8_from_Last_Year”>More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Hologic. HOLOGIC_Reports_Q3_FY2023_Revenue_of_984.4_Million_Net_Income_of_-40.5_Million_Down_1.8_from_Last_Year”>More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for Hologic are shown below. HOLOGIC_Reports_Q3_FY2023_Revenue_of_984.4_Million_Net_Income_of_-40.5_Million_Down_1.8_from_Last_Year”>More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
The company’s products are used in a variety of settings, including hospitals, clinics, and physician offices. Hologic also provides a range of services, including support, training, and education. The company has a strong presence in the United States and international markets, and its products are backed by a large body of scientific research. ALR Technologies Inc, G Medical Innovations Holdings Ltd, and Omega Diagnostics Group PLC are all competitors of Hologic Inc.
– ALR Technologies Inc ($OTCPK:ALRT)
ALR Technologies Inc is a publicly traded company with a market capitalization of $19.32 million as of 2022. The company has a return on equity of 17.26%. ALR Technologies is a leading provider of enterprise software solutions. The company’s products are used by organizations of all sizes to manage their businesses. ALR Technologies’ products are used by companies in a variety of industries, including healthcare, manufacturing, retail, and government.
– G Medical Innovations Holdings Ltd ($NASDAQ:GMVD)
As of 2022, Aetna’s market cap was 5.58M and its ROE was 783.79%. Aetna is a diversified healthcare benefits company that offers a broad range of traditional and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities and health care management services for Medicaid plans.
– Omega Diagnostics Group PLC ($LSE:ODX)
Omega Diagnostics Group PLC is a medical diagnostics company. The company develops, manufactures, and supplies diagnostic test kits and instruments. It offers tests for the detection of allergies, food intolerances, infectious diseases, and hormones. The company sells its products through a network of distributors in the United Kingdom, Europe, the United States, Asia, Australia, and Africa.
HOLOGIC reported a decrease in total revenue from $228.4 million to $984.4 million for the third quarter of Fiscal Year 2023, ending June 30 2023, along with a net income of -$40.5 million. This data indicates that investing in HOLOGIC would not be a sound investment. Investors should consider the decreased revenue and net income when deciding whether to invest in the company or not.
Factors such as market trends and industry developments should also be taken into account. Overall, HOLOGIC is not an ideal choice for investors looking to maximize their return on investment.